Sequitur Health Corp.

Sequitur Health Corp is a for-profit corporate entity registered in SAM.gov since December 2017, located in Scottsdale, Arizona. The company appears to specialize in developing advanced medical diagnostic technologies, with a particular focus on point-of-care metabolic measurement devices for rare metabolic disorders. While specific details about the company's founding or complete corporate history are not provided, the federal grant award documentation suggests the organization is dedicated to innovative medical technology development, particularly in creating diagnostic tools that enable at-home health monitoring.

The company has secured multiple significant federal grants from the National Institute of Child Health and Human Development (NICHD) and the National Science Foundation (NSF), focused on developing a sophisticated point-of-care diagnostic device for monitoring metabolite levels in patients with rare metabolic disorders. Through these grants, specifically R44HD112243, R44HD107897, and SB1HD116629, Sequitur Health Corp is working to create a home-based device that can accurately measure metabolites from a single drop of blood, potentially improving health outcomes for approximately 10,000 individuals with rare metabolic conditions. The company collaborates with prominent research institutions as subrecipients, including Texas A&M Engineering Experiment Station, Mayo Clinic Arizona, Arizona State University, and Oregon Health & Science University. Their research aims to develop a device that enables patients and caregivers to monitor metabolite levels, potentially reducing morbidity and mortality associated with metabolic crises, with the ultimate goal of obtaining FDA 510(k) clearance for their innovative technology.

Working to serve you to the best of our abilities.